Agenus
AGEN
#9227
Rank
$0.10 B
Marketcap
$2.99
Share price
-3.86%
Change (1 day)
-17.17%
Change (1 year)

Revenue for Agenus (AGEN)

Revenue in 2025 (TTM): $0.10 Billion USD

According to Agenus 's latest financial reports the company's current revenue (TTM ) is $0.10 Billion USD. In 2024 the company made a revenue of $0.10 Billion USD a decrease over the revenue in the year 2023 that were of $0.15 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agenus from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.10 B3.25%
2024 $0.10 B-33.81%
2023 $0.15 B59.46%
2022 $98.02 M-66.85%
2021 $0.29 B235.34%
2020 $88.16 M-41.24%
2019 $0.15 B307.92%
2018 $36.78 M-14.21%
2017 $42.87 M89.95%
2016 $22.57 M-9.04%
2015 $24.81 M255.67%
2014 $6.97 M129.13%
2013 $3.04 M-80.92%
2012 $15.96 M479.17%
2011 $2.75 M-17.97%
2010 $3.35 M0.75%
2009 $3.33 M25.78%
2008 $2.65 M-52.25%
2007 $5.55 M702.2%
2006 $0.69 M9.87%
2005 $0.62 M-10.9%
2004 $0.7 M-79.96%
2003 $3.52 M3.41%
2002 $3.41 M-25.1%
2001 $4.55 M929.08%
2000 $0.44 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
$92.14 B 86,158.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$64.23 B 60,028.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$48.03 B 44,863.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$42.35 B 39,545.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
$2.6 M-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA